Skip to content

Immunodiagnosis of active tuberculosis

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)521-532
Number of pages12
JournalExpert Review of Respiratory Medicine
Issue number6
Early online date28 May 2019
DateAccepted/In press - 3 May 2019
DateE-pub ahead of print - 28 May 2019
DatePublished (current) - 3 Jun 2019


Introduction: There is an unmet clinical need for improved diagnostic tests for active tuberculosis (TB) to provide high sensitivity for all cases, accelerate time to diagnosis and ensure timely and appropriate treatment. Whilst the measurement of M.tb-specific immune responses is widely used for detecting infection in the absence of TB symptoms (i.e. latent TB infection), there is currently no role for immunodiagnostics in active TB disease. This is primarily due to insufficient sensitivity, and an inability to discriminate between active disease and controlled, latent TB infection. Areas covered: In this review, we focus on recent developments in the use of immune-based tests to provide a point of care test for the rule-in or rule-out of active TB. Expert opinion: Recent studies have demonstrated that second-generation IGRAs have the potential to rule-out active TB, particularly in low burden settings. Newer technological platforms, including systems serology and flow cytometry, offer the means to measure specific M.tb specific immune signatures which have been shown to have a high level of accuracy for active TB. However, it is now crucial that new and promising test undergo validation in clinically relevant cohorts which include the full spectrum of TB patients and differential diagnoses.

    Research areas

  • Active tuberculosis, diagnostic test, immune response, immunodiagnosis, latent tuberculosis



  • Full-text PDF (accepted author manuscript)

    Rights statement: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Taylor & Francis at . Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 612 KB, PDF document

    Embargo ends: 28/05/20

    Request copy

    Licence: Other


View research connections

Related faculties, schools or groups